FEATURED, Genomics, News, Radiation, Regional Management, Risk Assessment
Influence of the subtype on local recurrence risk of breast cancer with or without radiotherapy
Breast Cancer Subtype May Be Predictive of Ipsilateral Breast Tumor Recurrence Studies have shown that certain intrinsic subtypes of breast cancer are associate...
FEATURED, Genomics, News, Risk Assessment, Histology
Standard Light Microscopy Illuminates a Molecular Mystery
Why do triple negative breast cancers in BRCA-1 patients have a better prognosis?
FEATURED, Genetics, News, Risk Assessment, Genetic Testing
Genome-wide Association Studies (GWAS) may be future for helping determine relative risk
Genetics have a thumb on the scale for just about every human trait Francis Collins, current Director of the NIH and member of the Human Genome Project, predic...
Research proves that not all DCIS patients need radiation therapy
Novel Signature Determines Recurrence Risk and Radiation Benefit for DCIS patients DCIS patients and their doctors have been plagued with “what to do now?” Add...
FEATURED, Neoadjuvant Treatment, News, BRCA, PARP Inhibitors
Neoadjuvant Single-Agent PARP Inhibitor Appears Promising in BRCA Patients
BRCA patients may be able to take only one pill a day in a neoadjuvant setting The results of a small phase II trial suggest that the PARP inhibitor, talazopari...
Risk Factors Identified for Recurrence after NeoAdjuvant Therapy
Simple clinical score assists decision-making following neoadjuvant therapy There is an increased use of neoadjuvant therapy (NAC) despite a lack of survival be...
FEATURED, Chemotherapy, Research, Fertility
Discussing Fertility with Younger Patients Facing Chemotherapy
Latest research shows possibility of ovarian preservation Approximately 50% of young patients with breast cancer are concerned about their risk of infertility a...
“Biosimilars” OK for Your Patients: Same Effectiveness. Lower Cost.
Trastuzumab Biosimilar ABP 980 Study Demonstrated Clinical Non-Inferiority Biosimilars are biologic products that are highly similar but have no clinically mean...
